108 related articles for article (PubMed ID: 5346883)
21. Some biologic, immunogenic, and morphologic effects in mice after infection with a murine sarcoma virus. II. Morphologic studies.
Stanton MF; Law LW; Ting RC
J Natl Cancer Inst; 1968 May; 40(5):1113-29. PubMed ID: 5689654
[No Abstract] [Full Text] [Related]
22. Rescue in vivo in adult mice of murine sarcoma virus (MSV) from a nonproducer rat neoplasm.
Law LW; Ting RC
Proc Soc Exp Biol Med; 1969 Jul; 131(3):960-3. PubMed ID: 5791815
[No Abstract] [Full Text] [Related]
23. Biological activity and separation of a leukaemogenic virus from murine sarcoma virus-Harvey (MSV-H).
Harvey JJ; East J
Int J Cancer; 1969 Sep; 4(5):655-65. PubMed ID: 4310639
[No Abstract] [Full Text] [Related]
24. Orthotopic bone induction at sites of Moloney murine sarcoma virus inoculation in mice.
Wlodarski K; Kobus M; Luczak M
Nature; 1979 Oct; 281(5730):386-7. PubMed ID: 225678
[TBL] [Abstract][Full Text] [Related]
25. Pathological effects in hamsters of murine sarcoma virus (MSV Harvey).
Chesterman FC; Phillips DE; Branca M; Bassin RH; Harvey JJ
J Pathol; 1970 Feb; 100(2):Pxi. PubMed ID: 5420785
[No Abstract] [Full Text] [Related]
26. Tumour regression and relapse in mice inoculated with murine sarcoma virus (Moloney).
Perk K; Russell E; Smith KL; Moloney JB
Lab Anim; 1973 Sep; 7(3):255-63. PubMed ID: 4795193
[No Abstract] [Full Text] [Related]
27. Enhancement of tumor development in physically-stressed mice inoculated with an oncogenic virus.
Seifter E; Rettura G; Zisblatt M; Levenson SM; Levine N; Davidson A; Seifter J
Experientia; 1973 Nov; 29(11):1379-82. PubMed ID: 4761246
[No Abstract] [Full Text] [Related]
28. Ribonucleic acid components of murine sarcoma and leukemia viruses.
Maisel J; Klement V; Lai MM; Ostertag W; Duesberg P
Proc Natl Acad Sci U S A; 1973 Dec; 70(12):3536-40. PubMed ID: 4357879
[TBL] [Abstract][Full Text] [Related]
29. Experimental osteosarcoma in the mouse, induced by Moloney's murine sarcoma virus.
Peretti G; Torri G; Marinoni EC; Facchini R; Scaglione P; Mantovani G
Ital J Orthop Traumatol; 1980 Aug; 6(2):255-68. PubMed ID: 6938501
[TBL] [Abstract][Full Text] [Related]
30. Enhancement of murine sarcoma virus (Moloney) infection and tumorigenesis in vivo by coinfection with Rauscher leukemia virus.
Turner W; Chirigos MA
Cancer Res; 1969 Nov; 29(11):1956-60. PubMed ID: 5358213
[No Abstract] [Full Text] [Related]
31. Biologic characterization and chemotherapeutic response of MS-2 tumor: a non-regressing mouse sarcoma derived from MSV-M-induced sarcoma.
Giuliani F; Bellini O; Casazza AM; Formelli F; Savi G; Di Marco A
Eur J Cancer (1965); 1978 May; 14(5):555-66. PubMed ID: 206445
[No Abstract] [Full Text] [Related]
32. Quantitative dose-response relationships of murine sarcoma virus (Moloney) in BALB/c mice.
Blumenschein GR; Moloney JB
J Natl Cancer Inst; 1969 Jan; 42(1):123-33. PubMed ID: 5765223
[No Abstract] [Full Text] [Related]
33. Treatment of Moloney virus-induced leukemia with cyclophosphamide and specifically sensitized allogeneic cells.
Glynn JP; Kende M
Cancer Res; 1971 Oct; 31(10):1383-8. PubMed ID: 5095130
[No Abstract] [Full Text] [Related]
34. Dietary zinc modulation of Moloney sarcoma virus oncogenesis.
Beach RS; Gershwin ME; Hurley LS
Cancer Res; 1981 Feb; 41(2):552-9. PubMed ID: 6256068
[No Abstract] [Full Text] [Related]
35. Potentiation of murine sarcoma virus (Harvey) (Moloney) oncogenicity in lactic dehydrogenase-elevating virus-infected mice.
Turner W; Ebert PS; Spahn G; Bassin R; Chirigos MA
Proc Soc Exp Biol Med; 1971 Apr; 136(4):1314-8. PubMed ID: 5554478
[No Abstract] [Full Text] [Related]
36. In vitro demonstration of in situ autologous tumour-cell cytotoxicity in MSV-induced tumours in A/SN mice.
Becker S; Haskill S
Br J Cancer; 1981 Mar; 43(3):284-93. PubMed ID: 7053211
[TBL] [Abstract][Full Text] [Related]
37. Functional activity in vivo of effector T cell populations. III. Protection against Moloney murine sarcoma virus (M-MSV)-induced tumors in T cell deficient mice by the adoptive transfer of a M-MSV-specific cytolytic T lymphocyte clone.
Cerundolo V; Lahaye T; Horvath C; Zanovello P; Collavo D; Engers HD
Eur J Immunol; 1987 Feb; 17(2):173-8. PubMed ID: 3030766
[TBL] [Abstract][Full Text] [Related]
38. Antigens of tumours induced by naturally occurring murine sarcoma virus (MSV-FBJ). II. Detection of cell-surface antigens by indirect membrane immunofluorescence.
Jones DB; Moore M
Br J Cancer; 1974 Feb; 29(2):158-67. PubMed ID: 4133783
[TBL] [Abstract][Full Text] [Related]
39. Titration patterns of a murine sarcoma-leukemia virus complex: evidence for existence of competent sarcoma virions.
O'Connor TE; Fischinger PJ
Science; 1968 Jan; 159(3812):325-9. PubMed ID: 4294341
[TBL] [Abstract][Full Text] [Related]
40. Murine sarcoma virus pseudotypes used as immunogens against viral and chemical oncogenesis.
BasombrÃo MA; Mayer AM; Pasqualini CD
Cancer Res; 1977 Jun; 37(6):1768-76. PubMed ID: 192461
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
